IGC Pharma, Inc. Annual Cost of Revenue in USD from 2010 to 2023

Taxonomy & unit
us-gaap: USD
Description
The aggregate cost of goods produced and sold and services rendered during the reporting period.
Summary
IGC Pharma, Inc. quarterly/annual Cost of Revenue history and growth rate from 2010 to 2023.
  • IGC Pharma, Inc. Cost of Revenue for the quarter ending June 30, 2024 was $109K, a 63.7% decline year-over-year.
  • IGC Pharma, Inc. Cost of Revenue for the twelve months ending June 30, 2024 was $421K, a 39.8% decline year-over-year.
  • IGC Pharma, Inc. annual Cost of Revenue for 2023 was $612K, a 30.5% increase from 2022.
  • IGC Pharma, Inc. annual Cost of Revenue for 2022 was $469K, a 131% increase from 2021.
  • IGC Pharma, Inc. annual Cost of Revenue for 2021 was $203K, a 74.1% decline from 2020.
Cost of Revenue, Trailing 12 Months (USD)
Cost of Revenue, Annual (USD)
Cost of Revenue, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $612K +$143K +30.5% Apr 1, 2023 Mar 31, 2024 10-K 2024-06-24
2022 $469K +$266K +131% Apr 1, 2022 Mar 31, 2023 10-K 2024-06-24
2021 $203K -$582K -74.1% Apr 1, 2021 Mar 31, 2022 10-K 2023-07-07
2020 $785K -$3.17M -80.2% Apr 1, 2020 Mar 31, 2021 10-K 2022-06-23
2019 $3.96M -$1.03M -20.6% Apr 1, 2019 Mar 31, 2020 10-K 2021-06-14
2018 $4.98M +$2.87M +136% Apr 1, 2018 Mar 31, 2019 10-K 2020-07-13
2017 $2.11M +$1.75M +483% Apr 1, 2017 Mar 31, 2018 10-K 2019-06-14
2016 $362K -$5.16M -93.4% Apr 1, 2016 Mar 31, 2017 10-K 2018-06-21
2015 $5.52M -$1.58M -22.2% Apr 1, 2015 Mar 31, 2016 10-K 2017-07-14
2014 $7.1M +$5.21M +275% Apr 1, 2014 Mar 31, 2015 10-K 2016-07-14
2013 $1.89M -$4.61M -70.9% Apr 1, 2013 Mar 31, 2014 10-K 2015-07-14
2012 $6.5M +$1.68M +34.8% Apr 1, 2012 Mar 31, 2013 10-K 2014-07-15
2011 $4.82M +$903K +23.1% Apr 1, 2011 Mar 31, 2012 10-K/A 2014-07-15
2010 $3.91M Apr 1, 2010 Mar 31, 2011 10-K 2012-07-16
* An asterisk sign (*) next to the value indicates that the value is likely invalid.